abstract |
Provided is a pharmaceutical composition comprising a liposome that encapsulates an immunosuppressant such as FK506, FTY720, or cyclosporine A as the active ingredient, which is effective in the treatment of inflammatory disease of the circulatory system such as myocardial infarction, myocarditis, or vasculitis syndrome and with which potentiation of activity at a smaller dose than with the immunosuppressant alone and a reduction in side effects are possible. |